{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:34Z","timestamp":1787010034044,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The impact and outcomes of postnatal cytomegalovirus (CMV) infection are not entirely clear. We aimed to determine the associations between treatment outcomes of postnatal CMV infection and its antiviral treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Retrospective study in a tertiary center. Infants of &lt; 29 weeks gestational age who were tested for postnatal CMV infection were included. CMV-infected infants were compared to uninfected infants (control group). CMV-infected infants were either treated with ganciclovir and\/or valganciclovir (CMV\n                      <jats:sub>PT<\/jats:sub>\n                      group) or not (CMV\n                      <jats:sub>PNT<\/jats:sub>\n                      group). Demographic, clinical, laboratory, treatment, and outcome data were collected. Primary outcomes were the length of stay, death before discharge and hearing impairment, cognitive and motor development as assessed by the Denver Developmental Screening Test II, and neurologic impairment at the corrected age of 1.5\u20132 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We included 103 extremely premature infants. The Median (interquartile range [IQR]) length of stay was 94 (69\u2013112) days in control, 85 (70\u2013102) days in CMV\n                      <jats:sub>PNT<\/jats:sub>\n                      , and 100 (88\u2013137) days in the CMV\n                      <jats:sub>PT<\/jats:sub>\n                      group. Mortality before discharge was 6% in control, 3.8% in CMV\n                      <jats:sub>PNT<\/jats:sub>\n                      , and 3.7% in the CMV\n                      <jats:sub>PT<\/jats:sub>\n                      group. Normal hearing at follow-up was found in 30\/37 infants in control (81.1%), 13\/13 infants in CMV\n                      <jats:sub>PNT<\/jats:sub>\n                      (100%), and 17\/20 infants in the CMV\n                      <jats:sub>PT<\/jats:sub>\n                      group (85%). Denver Developmental Screening Test II results did not differ among the three groups. Neurologic impairment was found in 21\/37 infants (56.8%) in control, 9\/13 infants in CMV\n                      <jats:sub>PNT<\/jats:sub>\n                      (69.2%), and 14\/20 infants in CMV\n                      <jats:sub>PT<\/jats:sub>\n                      group (70%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The associations between antiviral treatment of postnatal CMV infection and better treatment outcomes were nonsignificant.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003737","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T20:07:05Z","timestamp":1673640425000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Postnatal CMV Infection and Antiviral Treatment in Extremely Premature Infants: A 12-Year Retrospective Analysis"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5004-5819","authenticated-orcid":false,"given":"Rok","family":"Ko\u0161i\u010dek","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Kristan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Er\u010dulj","sequence":"additional","affiliation":[{"name":"Faculty of Criminal Justice and Security University, University of Maribor, 1000 Ljubljana, Slovenia"},{"name":"Rosigma, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-1150","authenticated-orcid":false,"given":"Lilijana","family":"Kornhauser Cerar","sequence":"additional","affiliation":[{"name":"Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Petrovec","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Pokorn","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Division of Pediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Spirovska","sequence":"additional","affiliation":[{"name":"Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ur\u0161i\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160tefan","family":"Grosek","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Division of Pediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/archdischild-2019-317650","article-title":"Postnatally acquired cytomegalovirus infection in extremely premature infants: how best to manage?","volume":"105","author":"Kadambari","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jamapediatrics.2019.4532","article-title":"Association of adverse hearing, growth, and discharge age outcomes with postnatal cytomegalovirus infection in infants with very low birth weight.","volume":"174","author":"Weimer","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1111\/j.1651-2227.2011.02538.x","article-title":"Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk.","volume":"101","author":"Bevot","year":"2012","journal-title":"Acta Paediatr"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2014.11.002","article-title":"Postnatal human cytomegalovirus infection in preterm infants has long-term neuropsychological sequelae.","volume":"166","author":"Brecht","year":"2015","journal-title":"J Pediatr"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"F430","DOI":"10.1136\/archdischild-2012-303384","article-title":"Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk.","volume":"98","author":"Goelz","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/hbm.22352","article-title":"Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study.","volume":"35","author":"Dorn","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1097\/MD.0000000000001835","article-title":"Outcome of preterm infants with postnatal cytomegalovirus infection via breast milk: a two-year prospective follow-up study.","volume":"94","author":"Jim","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"e20170635","DOI":"10.1542\/peds.2017-0635","article-title":"Outcome of preterm infants with postnatal cytomegalovirus infection.","volume":"141","author":"Gunkel","year":"2018","journal-title":"Pediatrics"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200404000-00009","article-title":"Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants.","volume":"23","author":"Vollmer","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jp.2011.58","article-title":"Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant.","volume":"32","author":"Okulu","year":"2012","journal-title":"J Perinatol"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/JCM.43.3.1318-1324.2005","article-title":"Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants.","volume":"43","author":"Meier","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000355306","article-title":"High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks\u2019 gestation after transmission via breast milk.","volume":"105","author":"Mehler","year":"2014","journal-title":"Neonatology"},{"key":"R13-20250614","first-page":"339","article-title":"Clinical features, treatment courses, and distribution of cytomegalovirus genotypes among thrombocytopenia patients aged younger than 12 months.","volume":"97","author":"Hu","year":"2020","journal-title":"Am J Perinatol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000260137","article-title":"Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant.","volume":"97","author":"Fischer","year":"2010","journal-title":"Neonatology"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000103982","article-title":"Severe postnatal cytomegalovirus infection in a very premature infant.","volume":"92","author":"Takahashi","year":"2007","journal-title":"Neonatology"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0000000000001407","article-title":"Symptomatic cytomegalovirus infections in the first year of life: when is antiviral therapy conceived to be justified?","volume":"36","author":"Schuster","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijantimicag.2010.11.033","article-title":"Ganciclovir treatment in children: evidence of subtherapeutic levels.","volume":"37","author":"Luck","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"F58","DOI":"10.1136\/adc.2007.131623","article-title":"Postnatal cytomegalovirus: innocent bystander or hidden problem?","volume":"94","author":"Luck","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12887-016-0683-x","article-title":"Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report.","volume":"16","author":"Sunada","year":"2016","journal-title":"BMC Pediatr"},{"key":"R21-20250614","first-page":"727","article-title":"Congenital cytomegalovirus infection [Prirojena oku\u017eba s citomegalovirusom].","volume":"75","author":"Rednak-Paradi\u017e","year":"2006","journal-title":"Zdrav Vestn"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.earlhumdev.2011.08.021","article-title":"Evidence based management guidelines for the detection and treatment of congenital CMV.","volume":"87","author":"Kadambari","year":"2011","journal-title":"Early Hum Dev"},{"issue":"suppl 4","key":"R26-20250614","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.","volume":"46","author":"Oliver","year":"2009","journal-title":"J Clin Virol"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease.","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management.","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.","volume":"92","author":"Papile","year":"1978","journal-title":"J Pediatr"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0039-1683958","article-title":"Cytomegalovirus infection among infants in neonatal intensive care units, California, 2005 to 2016.","volume":"37","author":"Tran","year":"2020","journal-title":"Am J Perinatol"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpeds.2005.09.030","article-title":"Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants.","volume":"148","author":"Neuberger","year":"2006","journal-title":"J Pediatr"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"e153785","DOI":"10.1001\/jamapediatrics.2015.3785","article-title":"Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia.","volume":"169","author":"Kelly","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/s-0036-1581080","article-title":"Symptomatic postnatal cytomegalovirus testing among very low-birth-weight infants: indications and outcomes.","volume":"33","author":"Mukhopadhyay","year":"2016","journal-title":"Am J Perinatol"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/INF.0b013e31825eb3e5","article-title":"Hearing in preterm infants with postnatally acquired cytomegalovirus infection.","volume":"31","author":"Nijman","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jmv.22230","article-title":"Prevalence of congenital cytomegalovirus infection in Slovenia: a study on 2,841 newborns.","volume":"84","author":"Paradi\u017e","year":"2012","journal-title":"J Med Virol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:01:45Z","timestamp":1749931305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003737","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,11]]}}}